SK4142003A3 - Substituted 3,4-dihydro-pyrido[1,2-A]pyrimidines, process for producing thereof, medicaments comprising same and their use - Google Patents

Substituted 3,4-dihydro-pyrido[1,2-A]pyrimidines, process for producing thereof, medicaments comprising same and their use Download PDF

Info

Publication number
SK4142003A3
SK4142003A3 SK414-2003A SK4142003A SK4142003A3 SK 4142003 A3 SK4142003 A3 SK 4142003A3 SK 4142003 A SK4142003 A SK 4142003A SK 4142003 A3 SK4142003 A3 SK 4142003A3
Authority
SK
Slovakia
Prior art keywords
unsubstituted
substituted
alkyl
mono
poly
Prior art date
Application number
SK414-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Matthias Gerlach
Corinna Sundermann
Utz-Peter Jagusch
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of SK4142003A3 publication Critical patent/SK4142003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK414-2003A 2000-10-13 2001-10-10 Substituted 3,4-dihydro-pyrido[1,2-A]pyrimidines, process for producing thereof, medicaments comprising same and their use SK4142003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050662A DE10050662A1 (de) 2000-10-13 2000-10-13 Substituierte 3,4-Dihydro-pyrido[1,2-a]pyrimidine
PCT/EP2001/011700 WO2002030933A1 (de) 2000-10-13 2001-10-10 Substituierte 3,4-dihydro-pyrido[1,2-a]pyrimidine

Publications (1)

Publication Number Publication Date
SK4142003A3 true SK4142003A3 (en) 2003-10-07

Family

ID=7659597

Family Applications (1)

Application Number Title Priority Date Filing Date
SK414-2003A SK4142003A3 (en) 2000-10-13 2001-10-10 Substituted 3,4-dihydro-pyrido[1,2-A]pyrimidines, process for producing thereof, medicaments comprising same and their use

Country Status (27)

Country Link
US (1) US7230103B2 (xx)
EP (1) EP1326866B1 (xx)
JP (1) JP4315678B2 (xx)
KR (1) KR20030036924A (xx)
CN (1) CN1255407C (xx)
AR (1) AR034266A1 (xx)
AT (1) ATE297927T1 (xx)
AU (2) AU1052602A (xx)
BR (1) BR0114734A (xx)
CA (1) CA2425666A1 (xx)
CO (1) CO5640115A2 (xx)
DE (2) DE10050662A1 (xx)
EC (1) ECSP034553A (xx)
ES (1) ES2241882T3 (xx)
HK (1) HK1057551A1 (xx)
HU (1) HUP0302464A2 (xx)
IL (2) IL155380A0 (xx)
MX (1) MXPA03003198A (xx)
NO (1) NO20031412L (xx)
NZ (1) NZ525652A (xx)
PE (1) PE20020435A1 (xx)
PL (1) PL361915A1 (xx)
PT (1) PT1326866E (xx)
RU (1) RU2003113966A (xx)
SK (1) SK4142003A3 (xx)
WO (1) WO2002030933A1 (xx)
ZA (1) ZA200303640B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10310106A1 (de) * 2003-03-06 2004-09-16 Grünenthal GmbH Substituierte Pyridot [1,2-a]pyrimidin-Verbindungen
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
EP2379566A2 (en) * 2008-12-22 2011-10-26 Schering Corporation Gamma secretase modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178910B (en) * 1977-08-19 1982-07-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines
US4666912A (en) * 1984-11-12 1987-05-19 Chinoin Gyogyszer Es Vegyeszeti Termeker Gyara Rt Treating process

Also Published As

Publication number Publication date
AR034266A1 (es) 2004-02-18
IL155380A (en) 2009-02-11
CN1255407C (zh) 2006-05-10
JP2004511484A (ja) 2004-04-15
CA2425666A1 (en) 2003-04-11
NZ525652A (en) 2005-01-28
ES2241882T3 (es) 2005-11-01
US7230103B2 (en) 2007-06-12
EP1326866B1 (de) 2005-06-15
HK1057551A1 (en) 2004-04-08
US20030229104A1 (en) 2003-12-11
DE50106542D1 (de) 2005-07-21
NO20031412L (no) 2003-04-22
ECSP034553A (es) 2003-05-26
WO2002030933A1 (de) 2002-04-18
EP1326866A1 (de) 2003-07-16
HUP0302464A2 (hu) 2003-11-28
RU2003113966A (ru) 2004-12-10
CN1479740A (zh) 2004-03-03
CO5640115A2 (es) 2006-05-31
KR20030036924A (ko) 2003-05-09
ZA200303640B (en) 2004-08-12
NO20031412D0 (no) 2003-03-27
JP4315678B2 (ja) 2009-08-19
BR0114734A (pt) 2003-07-01
ATE297927T1 (de) 2005-07-15
DE10050662A1 (de) 2002-04-18
PE20020435A1 (es) 2002-05-18
IL155380A0 (en) 2003-11-23
PT1326866E (pt) 2005-08-31
PL361915A1 (en) 2004-10-04
AU2002210526B2 (en) 2006-10-19
MXPA03003198A (es) 2004-05-21
AU1052602A (en) 2002-04-22

Similar Documents

Publication Publication Date Title
AU702324B2 (en) Cyclic GMP-specific phosphodiesterase inhibitors
AU2008236872B2 (en) Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof
JP5775871B2 (ja) ヘテロ環式オキシム化合物
MXPA98000411A (en) Quimi compounds
WO2007117180A1 (fr) Bibliothèques combinatoire et focalisée d'azahétérocycles, composition pharmaceutique et procédés de leur fabrication
CA3210332A1 (en) Tricyclic-amido-bicyclic prmt5 inhibitors
JP4559851B2 (ja) フェニルアミノピリミジンおよびＲｈｏ−キナーゼ阻害剤としてのその使用
SK11542003A3 (sk) Substituované pyrazolopyrimidíny a tiazolopyrimidíny, spôsob ich výroby, liečivá tieto látky obsahujúce a ich použitie
WO2002060907A1 (fr) Composes heterocycliques et compositions ameliorant les fonctions cerebrales contenant ces derniers comme principe actif
WO2009154870A1 (en) Hiv integrase inhibitors
SK4142003A3 (en) Substituted 3,4-dihydro-pyrido[1,2-A]pyrimidines, process for producing thereof, medicaments comprising same and their use
SK4152003A3 (en) Substituted 3,4-dihydro-pyrimido[1,2-a]pyrimidines and 3,4-dihydropyrazino[1,2-a]pyrimidines, process for producing thereof, medicaments comprising same and their use
ES2281251A1 (es) Nuevos derivados de pirido (3',2',4',5) furo (3,2-d) pirimidina.
TW202434582A (zh) Ｓｏｓ１抑制劑
TW202246261A (zh) 作為抗癌劑的化合物

Legal Events

Date Code Title Description
FC9A Refused patent application